Then, five candidate genes (DPT, ECT2, COL5A2, CTHRC1, and LRFN4) that were closely related to the survival rate of STAD patients were identified by analyzing the total survival information from STAD patients in the TCGA program. This evidence concerns the gene COL5A2 and gastric adenocarcinoma.